#
Tasmar
  • Treatments
  • Parkinson's Disease

Tasmar

Generic name:tolcaponeTOLE-ka-pone ]
Drug class:Dopaminergic antiparkinsonism agents

Medically reviewed by Drugs.com on Dec 31, 2021. Written by Cerner Multum.

What is Tasmar?

Tasmar is used together with other medicines (carbidopa and levodopa) to treat symptoms of Parkinson's disease, such as stiffness, tremors, muscle spasms, and poor muscle control. This medicine increases levels of levodopa in the body.

Tasmar is usually given to people who are already taking carbidopa and levodopa but have not had successful treatment of symptoms.

Tasmar may also be used for purposes not listed in this medication guide.

Warnings

You should not use Tasmar if you have liver disease, if you have ever had liver problems caused by Tasmar, or if you have ever had muscle damage or fever and confusion caused by using any medication.

Do not use Tasmar if you have used an MAO inhibitor in the past 14 days, such as isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, or tranylcypromine.

Tasmar can cause liver failure. Call your doctor at once if you have unusual tiredness, loss of appetite, dark urine, clay-colored stools, or jaundice (yellowing of the skin or eyes). Your liver function will need to be checked often.

Before taking this medicine

You should not use Tasmar if you are allergic to it, or if you have:

  • liver disease;

  • a history of liver problems caused by Tasmar; or

  • a history of muscle damage or fever and confusion caused by using any medication.

Do not use Tasmar if you have used an MAO inhibitor in the past 14 days. A dangerous drug interaction could occur. MAO inhibitors include isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, tranylcypromine, and others.

Tasmar can cause liver failure. You may be required to read and sign a Patient Consent form before you get a prescription for this medicine.

To make sure Tasmar is safe for you, tell your doctor if you have ever had: